CATHERINE HOUK: Open Payments
NPI 1225556269 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 6 payments from 5 companies in 2025. Trend: 2023 $113 · 2024 $16 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $46 |
| Octapharma USA, Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $19 |
| ARGENX US, INC. | 1 | $18 |
| TG Therapeutics, Inc. | 1 | $16 |
Products named: TREMFYA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Gamunex-C, VYVGART, BRIUMVI.
Industry payments across GA — which companies pay providers there.
